Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Pharmacotherapy and airway remodelling in asthma?

Beckett PA, Howarth PH.

Thorax. 2003 Feb;58(2):163-74. Review.

2.

Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma.

Wang K, Liu CT, Wu YH, Feng YL, Bai HL.

Adv Ther. 2008 Apr;25(4):342-54. doi: 10.1007/s12325-008-0048-4.

PMID:
18421428
3.

Airway wall remodelling: the influence of corticosteroids.

Ward C, Walters H.

Curr Opin Allergy Clin Immunol. 2005 Feb;5(1):43-8. Review.

PMID:
15643343
4.

Inhaled steroids and airway remodelling in asthma.

Chetta A, Marangio E, Olivieri D.

Acta Biomed. 2003 Dec;74(3):121-5. Review.

PMID:
15055015
5.

[Alternations of bronchial smooth muscle and effect of therapy on remodeling in asthma].

Pałgan K, Dziedziczko A, Bartuzi Z.

Pol Merkur Lekarski. 2006 Jul;21(121):5-7. Polish.

PMID:
17007282
6.

Therapeutic interventions aimed at reducing airway smooth muscle growth.

Martin JG, Greenstone EA, Maghni K.

Monaldi Arch Chest Dis. 2000 Aug;55(4):311-6. Review.

PMID:
11057085
7.

The role of leukotrienes in airway remodeling.

Mehrotra AK, Henderson WR Jr.

Curr Mol Med. 2009 Apr;9(3):383-91. Review.

PMID:
19355919
8.

Airway wall remodeling in asthma: from the epithelial layer to the adventitia.

Bossé Y, Paré PD, Seow CY.

Curr Allergy Asthma Rep. 2008 Jul;8(4):357-66. Review.

PMID:
18606090
9.

Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists.

Tomari S, Matsuse H, Hirose H, Tsuchida T, Fukahori S, Fukushima C, Kawano T, Matsuo N, Kohno S.

Respiration. 2008;76(4):398-402. doi: 10.1159/000151289. Epub 2008 Aug 11.

PMID:
18689991
10.

Airway smooth muscle and fibroblasts in the pathogenesis of asthma.

Johnson PR, Burgess JK.

Curr Allergy Asthma Rep. 2004 Mar;4(2):102-8. Review.

PMID:
14769258
11.

Airway remodelling in the pathogenesis of asthma.

Chiappara G, Gagliardo R, Siena A, Bonsignore MR, Bousquet J, Bonsignore G, Vignola AM.

Curr Opin Allergy Clin Immunol. 2001 Feb;1(1):85-93. Review.

PMID:
11964675
12.
13.

Observational study of the natural history of eosinophilic bronchitis.

Berry MA, Hargadon B, McKenna S, Shaw D, Green RH, Brightling CE, Wardlaw AJ, Pavord ID.

Clin Exp Allergy. 2005 May;35(5):598-601.

PMID:
15898981
14.

Pharmacologic modulation of airway inflammation.

O'Byrne PM, Gauvreau GM, Wood LJ.

Allergy. 1998;53(45 Suppl):41-7. No abstract available.

15.

Airway fibrosis in asthma: mechanisms, consequences, and potential for therapeutic intervention.

Redington AE.

Monaldi Arch Chest Dis. 2000 Aug;55(4):317-23. Review.

PMID:
11057086
16.

Airway remodelling in asthma: current understanding and implications for future therapies.

Tang ML, Wilson JW, Stewart AG, Royce SG.

Pharmacol Ther. 2006 Nov;112(2):474-88. Epub 2006 Jun 8. Review.

PMID:
16759709
17.

Airway remodeling is correlated with obstruction in children with severe asthma.

Tillie-Leblond I, de Blic J, Jaubert F, Wallaert B, Scheinmann P, Gosset P.

Allergy. 2008 May;63(5):533-41. doi: 10.1111/j.1398-9995.2008.01656.x.

18.

Endpoints in asthma drug trials--what do they mean?

[No authors listed]

Drug Ther Bull. 2006 Mar;44(3):21-4.

PMID:
16541670
19.

Is mild asthma really 'mild'?

Fabbri LM, Stoloff S.

Int J Clin Pract. 2005 Jun;59(6):692-703. Review.

PMID:
15924598
20.

Airway smooth muscle as an immunomodulatory cell: a new target for pharmacotherapy?

Lazaar AL, Panettieri RA Jr.

Curr Opin Pharmacol. 2001 Jun;1(3):259-64. Review.

PMID:
11712749
Items per page

Supplemental Content

Write to the Help Desk